SCHEMBL6317015

SCHEMBL6317015

CCOC(=O)c1cc(N=C=O)sn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.41
MAPT P10636 3/20 0.39
ALDH1A1 P00352 2/20 0.39
KMT2A Q03164 2/20 0.39
RAB9A P51151 2/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
GAA P10253 2/20 0.36
MAPK1 P28482 1/20 0.36
CYP2C19 P33261 2/20 0.36
GABRP O00591 2/20 0.36
GABRD O14764 2/20 0.36
GABRA1 P14867 2/20 0.36
GABRB1 P18505 2/20 0.36
GABRG2 P18507 2/20 0.36
GABRB3 P28472 2/20 0.36
GABRA5 P31644 2/20 0.36
GABRA3 P34903 2/20 0.36
GABRA2 P47869 2/20 0.36
GABRB2 P47870 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22609332 0.76 CYP1A2 (0.50) CYP1A2MAPTALDH1A1KMT2ARAB9A
SCHEMBL6312682 0.75 MEN1 (0.43) CYP1A2MAPTALDH1A1KMT2ARAB9A
SCHEMBL159255 0.74 CYP1A2 (0.49) CYP1A2MAPTALDH1A1KMT2ARAB9A
SCHEMBL17591778 0.73 MAPT (0.47) CYP1A2MAPTALDH1A1KMT2ARAB9A
SCHEMBL22890098 0.73 CYP1A2 (0.44) CYP1A2MAPTALDH1A1KMT2ARAB9A
SCHEMBL6313027 0.71 RAB9A (0.56) CYP1A2MAPTALDH1A1KMT2ARAB9A
SCHEMBL6312303 0.70
SCHEMBL9608829 0.70 MAPT (0.44) CYP1A2MAPTALDH1A1KMT2ARAB9A
SCHEMBL15932097 0.70 ALDH1A1 (0.44) CYP1A2MAPTALDH1A1KMT2ARAB9A
SCHEMBL17288520 0.66 ALDH1A1 (0.47) CYP1A2MAPTALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143581-A1 Process for preparation of alkoxybenzamides and thiazolyl isocyanates MITSUI CHEMICALS, INC. (JP) 2005-06-30 US disclosed
EP-1489073-A1 PROCESS FORPREPARATION OF ALKOXYBENZAMIDES AND THIAZOLYL ISOCYANATES MITSUI CHEMICALS, INC. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143581-A1 Process for preparation of alkoxybenzamides and thiazolyl isocyanates CBR3, CBR1, IDH1 CYP1A2 307/4885MAPT 3828/4885ALDH1A1 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.